Search Results - Guillermo Garcia‐Manero

Refine Results
  1. 1
    Myelodysplastic syndromes: 2015 Update on diagnosis, risk‐stratification and management

    Myelodysplastic syndromes: 2015 Update on diagnosis, risk‐stratification and management by Guillermo Garcia‐Manero

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Myelodysplastic syndromes: 2012 update on diagnosis, risk‐stratification, and management

    Myelodysplastic syndromes: 2012 update on diagnosis, risk‐stratification, and management by Guillermo Garcia‐Manero

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Demethylating agents in myeloid malignancies

    Demethylating agents in myeloid malignancies by Guillermo Garcia‐Manero

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management

    Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management by Guillermo Garcia‐Manero

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes

    Hypomethylating Agents and Other Novel Strategies in Myelodysplastic Syndromes by Guillermo Garcia‐Manero, Pierre Fenaux

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Novel drugs for older patients with acute myeloid leukemia

    Novel drugs for older patients with acute myeloid leukemia by Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero

    Published 2014
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Myelodysplastic syndromes: 2018 update on diagnosis, risk‐stratification and management

    Myelodysplastic syndromes: 2018 update on diagnosis, risk‐stratification and management by Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor

    Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor by Yanis Boumber, Anas Younes, Guillermo Garcia‐Manero

    Published 2011
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management

    Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management by Guillermo Garcia‐Manero, Kelly S. Chien, Guillermo Montalban‐Bravo

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    The Search for Better Prognostic Models in Myelodysplastic Syndromes

    The Search for Better Prognostic Models in Myelodysplastic Syndromes by Fabio P S Santos, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Farhad Ravandi

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation

    Emerging treatments for myelodysplastic syndromes: Biological rationales and clinical translation by Juan José Rodríguez‐Sevilla, Vera Ademà, Guillermo Garcia‐Manero, Simona Colla

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    AML outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients

    AML outcome: role of nucleotide excision repair polymorphisms in intermediate risk patients by Strom, Sara S, Estey, Elihu H, Outschoorn, Ubaldo Martinez, Guillermo, Garcia-Manero

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Evolution of decitabine development

    Evolution of decitabine development by Elias Jabbour, Jean–Pierre J. Issa, Guillermo Garcia‐Manero, Hagop M. Kantarjian

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    An MDS xenograft model utilizing a patient-derived cell line

    An MDS xenograft model utilizing a patient-derived cell line by Garrett W. Rhyasen, Mark Wunderlich, Kaoru Tohyama, Guillermo Garcia‐Manero, James C. Mulloy, Daniel T. Starczynowski

    Published 2013
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  15. 15
    Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia

    Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia by Craig A. Kovitz, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Lynne V. Abruzzo, Jorge E. Cortés

    Published 2006
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    The emerging role of immune checkpoint based approaches in AML and MDS

    The emerging role of immune checkpoint based approaches in AML and MDS by Prajwal Boddu, Hagop M. Kantarjian, Guillermo Garcia‐Manero, James P. Allison, Padmanee Sharma, Naval Daver

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Is acute myeloid leukemia a liquid tumor?

    Is acute myeloid leukemia a liquid tumor? by Maro Ohanian, Stefan Faderl, Farhad Ravandi, Naveen Pemmaraju, Guillermo Garcia‐Manero, Jorge E. Cortés, Zeev Estrov

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Chronic myelogenous leukemia: A review and update of therapeutic strategies

    Chronic myelogenous leukemia: A review and update of therapeutic strategies by Guillermo Garcia‐Manero, Stefan Faderl, Susan O’Brien, Jorge E. Cortés, Moshe Talpaz, Hagop M. Kantarjian

    Published 2003
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up

    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective a... by Mónica Cabrero, Elias Jabbour, Farhad Ravandi, Zach Bohannan, Sherry Pierce, Hagop M. Kantarjian, Guillermo Garcia‐Manero

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Fatigue, symptom burden, and health‐related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria

    Fatigue, symptom burden, and health‐related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria by Carmen P. Escalante, Stephanie Chisolm, Juhee Song, Marsha Richardson, Ellen Salkeld, Etsuko Aoki, Guillermo Garcia‐Manero

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: